Topline data were announced from a phase 3 trial evaluating somapacitan in children born small for gestational age, with Noonan syndrome, or with idiopathic short stature.

Growth patterns during the first two years of a child's life may shape pubertal growth and adult height, but have little ...

At Children’s Hospital of Philadelphia, Executive Vice President and CFO Sophia Holder is entering her fifth year in the role with pediatric growth opportunities on her mind, and a goal of continuing ...

New Chief Legal Officer brings extensive nonprofit knowledge and strategic leadership experience OKLAHOMA CITY, OK / ACCESS Newswire / May 20, 2025 / Feed the Children is continuing its forward ...

With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in ...

Somapacitan was noninferior to somatropin in improving yearly growth rate in children born SGA, or with NS or ISS. Topline data were announced from a phase 3 trial evaluating somapacitan in pre ...

The REAL8 basket study showed Sogroya (somapacitan) was non-inferior to Norditropin (somatropin) in improving yearly growth ...

The research, published in Nature Human Behavior, analyzed MRI scans from over 1,000 children to map how different brain ...

Syracuse, NY -- Upstate’s pediatric primary care practice is nearly doubling its footprint in Syracuse’s northern suburbs in ...

Longer breastfeeding duration is associated with greater cortical thickness, surface area, and improved fluid cognition in ...

Pediatric pituitary adenomas and cysts were incidentally rare and tended to be small, nonfunctioning, and stable among children and adolescents.

Children need to be kept safe online. But Meta's AI chatbots spark controversy over sexual material. Parents' group calls for ...